Brand-specific rates of pertussis disease among Wisconsin children given 1-4 doses of pertussis Vaccine, 2010-2014.

DISCUSSION: Pertussis protection was not found to differ for recipients of the newly licensed vs other available pertussis vaccines. Delayed vaccination substantially increased risk of pertussis. Sample survey methodology was able to characterize the study cohort and enable an otherwise-infeasible study. Clinical Trial Registry number: ClinicalTrials.gov, NCT01129362. PMID: 32921507 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32921507?dopt=Abstract

Source: Vaccine - September 9, 2020 Category: Allergy & Immunology Authors: Conway JH, Davis JP, Eickhoff JC, Pool V, Greenberg DP, Decker MD Tags: Vaccine Source Type: research